Cargando...

Prognostic value of Ki-67 immunolabelling in primary operable breast cancer.

The prognostic value of Ki-67 immunohistochemical labelling was evaluated in 327 operable primary carcinomas of the breast. The follow-up time was up to 4 years (mean 2.7 years). The disease-free survival in Ki-67 positive patients was shorter than in Ki-67 negative patients (P < 0.005). By combi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Railo, M., Nordling, S., von Boguslawsky, K., Leivonen, M., Kyllönen, L., von Smitten, K.
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group 1993
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC1968381/
https://ncbi.nlm.nih.gov/pubmed/8394732
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!